INOZYME PHARMA, INC. Temporary Equity, Liquidation Preference
INOZYME PHARMA, INC. had Temporary Equity, Liquidation Preference of $116.25 million as of 2020-06-30, per its 10-Q filed 2020-09-03.
Discontinued › Balance Sheet › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2021-03-25
- 2020-06-30: Temporary Equity, Liquidation Preference $116.25M.
- 2019-12-31: Temporary Equity, Liquidation Preference $82.55M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2020-06-30 | $116.25M 10-Q · filed 2020-09-03 |
| 2019-12-31 | $82.55M 10-K · filed 2021-03-25 |